Stock Events

Stock Events

Oncolys BioPharma (4588.TSE) Q1 2026 Earnings

6FebConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-31.65

-25.17

-18.69

-12.22

Details

Expected EPS

N/A

Actual EPS

-15.417542483999998

Surprise EPS

-15.42

Surprise Percent

+∞%

Description

Oncolys BioPharma (4588.TSE) has reported earnings of -15.417542483999998 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.